Source: Abstracts : Evolving alternatives to risk assessment and toxicology data gaps. Conference titles: Toxicology and Risk Assessment Conference. Unidades: FZEA, FMRP
Subjects: AFLATOXINAS, FÍGADO, PACIENTES, CIRROSE HEPÁTICA, CARCINOMA HEPATOCELULAR
ABNT
PORTA, Livia Della et al. Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil. 2016, Anais.. Cincinnati: Faculdade de Zootecnia e Engenharia de Alimentos, Universidade de São Paulo, 2016. . Acesso em: 18 nov. 2024.APA
Porta, L. D., Rosim, R. E., Petta, T., Di Gregorio, M. C., Ramalho, F. S., Ramalho, L. N. Z., et al. (2016). Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil. In Abstracts : Evolving alternatives to risk assessment and toxicology data gaps. Cincinnati: Faculdade de Zootecnia e Engenharia de Alimentos, Universidade de São Paulo.NLM
Porta LD, Rosim RE, Petta T, Di Gregorio MC, Ramalho FS, Ramalho LNZ, Augusto MJ, Oliveira CAF de. Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil. Abstracts : Evolving alternatives to risk assessment and toxicology data gaps. 2016 ;[citado 2024 nov. 18 ]Vancouver
Porta LD, Rosim RE, Petta T, Di Gregorio MC, Ramalho FS, Ramalho LNZ, Augusto MJ, Oliveira CAF de. Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil. Abstracts : Evolving alternatives to risk assessment and toxicology data gaps. 2016 ;[citado 2024 nov. 18 ]